Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss of $0.37

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported Q3 EPS of ($0.37), versus ($0.43) reported last year.

For earnings history and earnings-related data on Cyclacel Pharmaceuticals, Inc. (CYCC) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
• Unity Bancorp CEO to retire in 2027, president to take over